Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesIn Defense of the Whipple: An Argument for Aggressive Surgical Management of Pancreatic Cancer
The Oncologist, 06/22/09
Chamberlain RS et al. - Whereas death rates for cancers of the stomach, lung, colon, and prostate have decreased over the past 20 years, death rates from pancreatic cancer have remained stable, with a slow increase in those aged >70 years. Although some of this may be a result of an increased overall life expectancy, the natural history of pancreatic cancer, lack of early detection strategies, inability to adequately identify at-risk populations, and aggressive biology play important roles in the disease's lethality, and remain a challenge to its treatment.
Today in Hepatobiliary/Pancreas...keeping you current
Receive free subspecialty "5-minute updates" via email
Surgical management of hepatocellular carcinoma: Is the jury still out
Surgical Oncology, 11/05/09
Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials
British Journal of Cancer, 11/13/09
Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report
World Journal of Surgical Oncology, 11/09/09
Sponsor
Article Search
Sponsor
Sponsor